135066-21-6 Usage
General Description
4-tert-Butoxyphenylacetic acid is a chemical compound with a molecular formula C12H16O3. It is commonly used as an intermediate in the synthesis of pharmaceuticals and agrochemicals. 4-TERT-BUTOXYPHENYLACETIC ACID is a derivative of phenylacetic acid and contains a tert-butoxy group attached to the phenyl ring. It is a white crystalline solid with a melting point of 79-83°C. This chemical is known for its potential therapeutic effects, including anti-inflammatory and analgesic properties, and is used in the manufacturing of medications for pain relief and anti-inflammatory treatments. Additionally, it has been studied for its potential as an inhibitor of fatty acid amide hydrolase, an enzyme involved in the regulation of endocannabinoid signaling. Overall, 4-tert-butoxyphenylacetic acid is a versatile compound with various potential applications in the pharmaceutical and agricultural industries.
Check Digit Verification of cas no
The CAS Registry Mumber 135066-21-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,5,0,6 and 6 respectively; the second part has 2 digits, 2 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 135066-21:
(8*1)+(7*3)+(6*5)+(5*0)+(4*6)+(3*6)+(2*2)+(1*1)=106
106 % 10 = 6
So 135066-21-6 is a valid CAS Registry Number.
135066-21-6Relevant articles and documents
A novel constrained reduced-amide inhibitor of HIV-1 protease derived from the sequential incorporation of γ-turn mimetics into a model substrate
Newlander,Callahan,Moore,Tomaszek Jr.,Huffman
, p. 2321 - 2331 (2007/10/02)
C7 mimetics, designed to lock three amino acid residues of a peptide chain into a γ-turn conformation, were introduced sequentially between the P3 to P2' positions of a model HIV-1 protease substrate I (resulting in compou
